drugset / Trial / NCT02957474
A Study to Evaluate the Effect of Food, Formulation Strength, and a Proton Pump Inhibitor on GED 0301 Pharmacokinetics in Healthy Adult Subjects
RandomizedCrossoverOpen-labelTreatment
Summary
This is an open label, single-center, 4-period, 6-sequence study in healthy subjects to compare the PK of GED 0301 after a single oral dose in the fed and fasted state, and after co administration with omeprazole, a proton pump inhibitor. The study will consist of a screening phase, a baseline phase, four treatment periods, and a follow up phone call five days (± 1 day) after discharge.
Timeline
- Start
- 2016-11
- Primary completion
- 2016-12
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | MONGERSEN SODIUM | Antisense oligonucleotide | 160 mg | Oral |
| Subject | Omeprazole | Other / unclassified | 40 mg | Oral |
Indications
No indication recorded.